PLYX
Financials
- Market Capitalization 102.68 M
- Employee 7
- Founded 2014
- CEO N/A
- Website www.polaryx.com
- Headquarter Wyoming, United States
- FIGI BBG01ZPFWW22
- Industry Drug Manufacturers—General
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 3336 |  AMRN Amarin Corporation plc - American Depositary Shares, each repre | 13.97 USD | -0.71% | -0.85% | -1.13% | -10.22% | 295.09 M USD | ||
| 3745 |  OKUR OnKure Therapeutics, Inc. - Class A Common Stock | 3.79 USD | -1.04% | -5.49% | -3.56% | +54.69% | 153.48 M USD | ||
| 3966 |  PTHS Pelthos Therapeutics Inc. Common Stock | 24.46 USD | -2.28% | -3.13% | -5.78% | +3.78% | 93.64 M USD | ||
| 3982 |  DWTX Dogwood Therapeutics, Inc. - Common Stock | 2.65 USD | +14.22% | +0.38% | +74.34% | -11.67% | 90.08 M USD |
Frequently asked questions about Polaryx Therapeutics, Inc. Common Stock
What is the Polaryx Therapeutics, Inc. Common Stock stock price today?
The current price of Polaryx Therapeutics, Inc. Common Stock (PLYX) is 2.06. Over the past 24 hours, the stock has changed by -2.37%. Follow the PLYX chart for real-time price dynamics.
What is the stock ticker of Polaryx Therapeutics, Inc. Common Stock?
Polaryx Therapeutics, Inc. Common Stock trades under the ticker PLYX. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Polaryx Therapeutics, Inc. Common Stock stock going up?
PLYX has changed by -0.96% over the last week, +1.98% over the last month, and -95.42% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Polaryx Therapeutics, Inc. Common Stock?
Polaryx Therapeutics, Inc. Common Stock currently has a market capitalization of 102.68 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were Polaryx Therapeutics, Inc. Common Stock earnings last quarter?
Last quarter, Polaryx Therapeutics, Inc. Common Stock reported earnings of -0.03 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Polaryx Therapeutics, Inc. Common Stock net income for the last quarter?
Polaryx Therapeutics, Inc. Common Stock reported net income of -1.38 M for the last quarter. The previous quarter showed -2.54 M, which means net income changed by +45.75%.
How many employees does Polaryx Therapeutics, Inc. Common Stock have?
As of the latest available data, Polaryx Therapeutics, Inc. Common Stock has 7 employees. Workforce size can provide additional context about the company's scale and operations.
How can I buy Polaryx Therapeutics, Inc. Common Stock stock?
You can buy Polaryx Therapeutics, Inc. Common Stock (PLYX) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Polaryx Therapeutics, Inc. Common Stock stock?
Investing in Polaryx Therapeutics, Inc. Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the PLYX chart and related analysis on metatrader.com as part of your research.